Abstract 2256P
Background
In this study, we aimed to investigate the microenvironment of normal mucosa to predict prognosis of stage II/III colorectal cancer (CRC), after surgery.
Methods
We divide the groups using transcriptome sequencing data of prospectively collected tumors and paired normal tissue, obtained from the margins of the resected specimens from 111 patients at Samsung medical center. Groups were defined as follows: tumor-like microenvironment in normal mucosa group (tNME): high tumor signature in normal mucosa; normal microenvironment group (NME): low tumor signature in normal mucosa. The impact of this classification was further evaluated in two independent cohorts (Korean multi-center cohort and TCGA cohort). The microbial, and biological differences between groups were investigated based on 16s rRNA metagenomics and single-cell RNA sequencing.
Results
A total of 38 (34%) were classified as tNME. There were no significant differences in age, sex, TNM stage and CMS between subgroups. With a median follow-up of 57.9 months, tNME showed poorer 3-year recurrence-free survival (RFS) (56.0 % vs. 78.9 %, P=0.008) and 3-year overall survival (OS) (79.0 %vs. 87.7%, P=0.095) compared to NME. These were validated in the Korean multi-center validation cohort (3-year RFS: 55.3% vs. 74.5%, P=0.045), and TCGA cohort (3-year OS: 62.2% vs. 91.7%, P=0.071). Metagenomics exhibited a significantly lower proportion of carcinogenic genus including Fusobacterium, Bacteroides in normal of NME. There were significant differences in beta diversity between tumor and normal in NME, while no significant differences were noted in tNME, which suggests the feature of bacterial biofilm. PathSeq-based computational method of single-cell RNA sequencing revealed more proportion of infected cancer cells in tNME. EMP1 +epithelial cells were correlated with recurrence, and more proportion of this cluster, along with GZMK high CD8 T cells, inflammatory cancer-associated fibroblasts were noted in tumor of tNME, while more proportion of neutrophil was noted in normal of tNME.
Conclusions
The microenvironment of normal mucosa status could be a prognostic biomarker for CRC. The bacterial biofilm with weak intestinal barrier were related to tNME.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Bio & Medical Technology Development Program of the National Research Foundation funded by the Ministry of Science & ICT (grant no. NRF2017M3A9A7050803.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2315P - Clinical and blood immune-inflammatory profiling to decode different patterns of acquired resistance in immunotherapy treated NSCLC patients
Presenter: Giulia Mazzaschi
Session: Poster session 08
2316P - Integrating comprehensive cancer genome profiling into clinical practice in an Italian referral center: Results of the first year of the fpg500 programme
Presenter: Camilla Nero
Session: Poster session 08
2317P - Mutational landscape and therapeutic implications in squamous cell carcinomas
Presenter: Laila Belcaid
Session: Poster session 08
2318P - Value of broad molecular profiling for cancer diagnosis
Presenter: Lars Volker Anton Werstein
Session: Poster session 08
2319P - CADSP: A web tool for comprehensive drug sensitivity analysis in pan-cancer
Presenter: Kexin Li
Session: Poster session 08
2320P - Detection of gene fusion-induced neoepitopes in dedifferentiated liposarcoma
Presenter: Peter Horak
Session: Poster session 08
2321TiP - TEMPLE: Thiopurine enhanced mutations for PD-1/ligand-1 efficacy: A phase Ib/II clinical trial
Presenter: Christine Federspiel Secher
Session: Poster session 08
2322TiP - SOUND: A phase II trial evaluating the efficacy of molecular profiling of circulating ± tumor tissue DNA for salvage-therapy matching in patients with advanced and refractory carcinoma
Presenter: Jakob Riedl
Session: Poster session 08